Drugs / Doxofylline

Trials 5 · a red edge is where a trial was stopped

20092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT03879590 May → Sep 2019 childhood onset asthma, chronic asthma Autonomous University of Nuevo León Unknown No outcome recorded
Phase 43 trials
Phase 4 NCT04238221 Dec 2026 → Dec 2027 expected chronic obstructive pulmonary disease University of Milan Not yet recruiting No outcome recorded
Phase 4 NCT06346691 Mar → Oct 2024 chronic obstructive pulmonary disease Thammasat University Completed No outcome recorded
Phase 4 NCT03388853 Feb 2018 → Dec 2019 chronic obstructive pulmonary disease Neutec Ar-Ge San ve Tic A.Ş Completed No outcome recorded
Phase not applicable1 trial
NCT01055041 Dec 2008 → Jun 2009 chronic asthma Government Medical College, Bhavnagar Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as Doxofylline ClinicalTrials.gov intervention name — accepted as the source's own label NCT03388853
2

NCT06346691

NCT04238221

Known as ABC 12/3 ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608
Known as Ansimar ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608
Known as Dioxyfilline ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608
Known as Doxofilina ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608
Known as doxophylline ClinicalTrials.gov intervention name — accepted as the source's own label NCT01055041
1

NCT03879590

Known as NSC-759645 ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608
Known as Synasma ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608
Known as Ventax ChEMBL registry synonym — accepted as the source's own label CHEMBL1527608
Modality Small molecule CHEMBL1527608
Route Oral “plus tablet doxophylline sustained release(400 mg/day)orally in the morning” NCT01055041